Adverse prognosis of bulky disease in good-risk DLBCL. [electronic resource]
Producer: 20080515Description: 406-7 p. digitalISSN:- 1474-5488
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Humans
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Neoplasm Staging
- Patient Selection
- Prednisone -- administration & dosage
- Prognosis
- Proportional Hazards Models
- Radiotherapy, Adjuvant
- Risk Assessment
- Rituximab
- Time Factors
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Comment; Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.